InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（30 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
30
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Ticho Barry, Directeur Médical. Director active across 1 company, notably Stoke Therapeutics, Inc.. Aggregated, 48 disclosures have been recorded. Split: 0 buy · 30 sells. Total volume traded: €3.3m. Activity tracked since 13 July 2021. The latest transaction was disclosed on 1 September 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ticho Barry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报48 总计
3,945 股@ US$30.512Common StockSEC:0001780088-26-000021:0
1,600 股@ US$31.0569Common StockSEC:0001780088-26-000021:1
10,000 股0Common StockSEC:0001780088-26-000019:0
4,525 股@ US$32.00720.0070% mcap3.9% 占其流量Common StockSEC:0001780088-26-000019:1
242 股@ US$32.46810.0004% mcap0.2% 占其流量Common StockSEC:0001780088-26-000019:2
1,269 股@ US$29.45390.0018% mcap1.1% 占其流量Common StockSEC:0001780088-26-000017:1
5,907 股@ US$28.95010.0084% mcap4.8% 占其流量Common StockSEC:0001780088-26-000017:0
6,728 股@ US$32.6150.011% mcap5.7% 占其流量Common StockSEC:0001780088-26-000015:0
500 股@ US$33.26780.0008% mcap0.4% 占其流量Common StockSEC:0001780088-26-000015:1
1,838 股@ US$32.661.5% 占其流量Common StockSEC:0001780088-26-000009:0
3,577 股@ US$32.73944.0% 占其流量Common StockSEC:0001780088-26-000006:0
13,100 股0Common StockSEC:0001780088-26-000004:0
10,000 股0Common StockSEC:0001780088-25-000006:0
11,981 股0Common StockSEC:0001780088-25-000005:0
3,776 股@ US$25.22422.9% 占其流量Common StockSEC:0001780088-25-000004:0
5,343 股@ US$23.64143.8% 占其流量Common StockSEC:0001780088-25-000003:0
5,501 股@ US$19.87373.5% 占其流量Common StockSEC:0001415889-25-023591:0
2,805 股@ US$18.2381.7% 占其流量Common StockSEC:0001415889-25-022442:0
10,000 股0Common StockSEC:0001415889-25-022227:0
4,504 股@ US$12.81622.0% 占其流量Common StockSEC:0001415889-25-021024:0
4,503 股@ US$11.63211.8% 占其流量Common StockSEC:0001415889-25-019004:0
1,745 股@ US$10.000.6% 占其流量Common StockSEC:0001415889-25-015693:0
3,841 股@ US$10.001.1% 占其流量Common StockSEC:0001415889-25-011940:0
3,884 股@ US$8.671.0% 占其流量Common StockSEC:0001415889-25-008710:0
13,100 股0Common StockSEC:0001415889-25-008359:0
48 条申报中的 25 条
About Ticho Barry
Ticho Barry is Chief Medical Officer at Stoke Therapeutics, Inc. (XNAS). He has 41 filings in total, and the recent filings tracked run from 2021-07-15 to 2026-07-06, with EUR 0 in purchases and EUR 2,838,042 in sales.
